Natera (NTRA) Q3 2026 earnings — TrendMatrix coverage
Reported
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure · Editorial policy
Key numbers
- Adjusted EPS
- -$0.42
- Estimate
- -$0.28
- Surprise
- -49.2%
- Revenue (period 2026-09-30)
- $794.0M
- Score today
- 5.9/10
Revenue source: xbrl.
How the report landed
Natera (NTRA) reported a wider loss than forecast — adjusted EPS of -$0.42 against the -$0.28 estimate (a 49.2% shortfall).
Coverage in the report window
- Natera Stock Plummets After Mixed Q3 Financials — benzinga, 2026-11-06
- If You Invested $100 In Natera Stock 10 Years Ago, You Would Have This Much Today — benzinga, 2026-11-06
Where TrendMatrix's rating stands now
TrendMatrix currently rates NTRA Sell at 5.9/10; no pre/post engine snapshot brackets this report.
2 of the last 4 quarters beat the estimate; this quarter's -49.2% surprise compares with a +30.4% four-quarter average.
What supports the rating
- Sector modifier (Healthcare): +0.5
- Strong growth profile
What argues against it
- V7 low-quality RISK_OFF penalty: -0.5 (Q=4.6)
- Consecutive earnings misses (2)
- Negative news sentiment (-0.60)
This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.
The levels TrendMatrix's engine tracks
- Current price
- $315.28
- Price target
- $374.75
- Stop
- $294.88
- Upside to target
- +18.9%
- Reward-to-risk
- 1.3:1
Risk check: RSI 30 — a level conventionally read as oversold.
Model outputs from TrendMatrix’s engine as of 2026-11-06 — shown for context, not personalized investment advice.
NTRA at TrendMatrix's latest read
Healthcare earnings trade on pipeline and payer dynamics as much as the quarter itself; a beat or miss is weighed against trial and reimbursement news.
- Industry
- Diagnostics & Research
- Market cap
- $52.43B
- P/E (fwd)
- -1575.3
- 52-week range
- $181.00–$437.41
- Off 52-week high
- 27.9%
- RSI (14)
- 30
- Volume vs avg
- 1.46×
- Score today
- 5.9/10